Nuria Porta

Regulatory watch: Where do new medicines originate from in the EU?

H. Eichler, C. Ziogas, Helene Lincker, 2014, Nature Reviews Drug Discovery.

Molecular similarity considerations in the licensing of orphan drugs.

P. Willett, J. Holliday, Nuria Porta, 2017, Drug discovery today.

The use of 2D fingerprint methods to support the assessment of structural similarity in orphan drug legislation

Peter Willett, John D. Holliday, Pedro Franco, 2014, Journal of Cheminformatics.